| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study S Sacchi, L Marcheselli, A Bari, R Marcheselli, S Pozzi, S Luminari, ... Haematologica 93 (3), 398-404, 2008 | 129 | 2008 |
| Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story A Bari, L Marcheselli, S Sacchi, R Marcheselli, S Pozzi, P Ferri, E Balleari, ... Annals of Oncology 21 (7), 1486-1491, 2010 | 120 | 2010 |
| Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis S Pozzi, L Marcheselli, A Bari, EV Liardo, R Marcheselli, S Luminari, ... British journal of haematology 163 (1), 40-46, 2013 | 102 | 2013 |
| Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program M Ladetto, C Lobetti-Bodoni, B Mantoan, M Ceccarelli, C Boccomini, ... Blood, The Journal of the American Society of Hematology 122 (23), 3759-3766, 2013 | 100 | 2013 |
| Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis M Pirani, R Marcheselli, L Marcheselli, A Bari, M Federico, S Sacchi Annals of Oncology 22 (8), 1845-1858, 2011 | 96 | 2011 |
| Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post … T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ... haematologica 99 (1), 125, 2014 | 95 | 2014 |
| Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy S Luminari, M Cesaretti, I Rashid, C Mammi, A Montanini, E Barbolini, ... Hematological oncology 25 (4), 189-197, 2007 | 76 | 2007 |
| Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced … U Vitolo, M Ladetto, C Boccomini, L Baldini, F De Angelis, A Tucci, B Botto, ... Journal of clinical oncology 31 (27), 3351-3359, 2013 | 68 | 2013 |
| Introduction of rituximab in front‐line and salvage therapies has improved outcome of advanced‐stage follicular lymphoma patients S Sacchi, S Pozzi, L Marcheselli, A Bari, S Luminari, F Angrilli, F Merli, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 66 | 2007 |
| Neutrophil‐lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving … R Marcheselli, A Bari, T Tadmor, L Marcheselli, MC Cox, S Pozzi, ... Hematological oncology 35 (4), 561-566, 2017 | 59 | 2017 |
| Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma L Marcheselli, R Marcheselli, A Bari, EV Liardo, F Morabito, L Baldini, ... Leukemia & lymphoma 52 (10), 1867-1872, 2011 | 54 | 2011 |
| Empathic attitudes among nursing students: a preliminary study P Ferri, S Rovesti, N Panzera, L Marcheselli, A Bari, R Di Lorenzo Acta Bio Medica: Atenei Parmensis 88 (Suppl 3), 22, 2017 | 53 | 2017 |
| Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: evaluation based on data from 1450 patients T Tadmor, A Bari, L Marcheselli, S Sacchi, A Aviv, L Baldini, PG Gobbi, ... Mayo Clinic Proceedings 90 (6), 756-764, 2015 | 53 | 2015 |
| Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher‐risk myelodysplastic syndromes or chronic myelomonocytic leukemia MT Voso, M Breccia, M Lunghi, A Poloni, P Niscola, C Finelli, A Bari, ... European journal of haematology 90 (4), 345-348, 2013 | 51 | 2013 |
| Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? F Di Raimondo, L Caruso, G Bonanno, P Naso, A Chiarenza, P Fiumara, ... Annals of oncology 18 (2), 351-356, 2007 | 48 | 2007 |
| Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas RM Santi, M Ceccarelli, E Bernocco, C Monagheddu, A Evangelista, ... Thrombosis and Haemostasis 117 (08), 1615-1621, 2017 | 47 | 2017 |
| Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study S Sacchi, L Marcheselli, A Bari, R Marcheselli, S Pozzi, PG Gobbi, ... haematologica 93, 1335-1342, 2008 | 47 | 2008 |
| The undergraduate nursing student evaluation of clinical learning environment: an Italian survey D Magnani, R Di Lorenzo, A Bari, S Pozzi, C Del Giovane, P Ferri Professioni infermieristiche 67 (1), 2014 | 38 | 2014 |
| Risk of second primary malignancy in breast cancer survivors: a nested population-based case-control study R Marcheselli, L Marcheselli, L Cortesi, A Bari, C Cirilli, S Pozzi, P Ferri, ... Journal of Breast Cancer 18 (4), 378, 2015 | 34 | 2015 |
| Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas A Bari, T Tadmor, S Sacchi, L Marcheselli, EV Liardo, S Pozzi, S Luminari, ... Leukemia research 37 (6), 619-623, 2013 | 33 | 2013 |
